Stage III Chronic Lymphocytic Leukemia

specific

Risk: Intermediate; Findings: Lymphocytosis, adenopathy, and enlarged spleen and/or liver; Survival (months): 72. (from AJCC 8th Ed.)

62

Centers

57

Active Trials

Cancer Funding

Top Centers for Stage III Chronic Lymphocytic Leukemia(62)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.6
2
NCI Comprehensive
Active Research Program
52.6
3
NCI Comprehensive
Active Research Program
52.6
4
NCI Comprehensive
Active Research Program
52.6
5
NCI Comprehensive
Active Research Program
52.6
6
NCI Comprehensive
Active Research Program
52.6
7
NCI Comprehensive
Active Research Program
52.6
8
NCI Comprehensive
Active Research Program
52.6
9
NCI Comprehensive
Active Research Program
52.6
10
NCI Comprehensive
Active Research Program
52.6
11
NCI Comprehensive
Active Research Program
52.6
12
NCI Comprehensive
Active Research Program
52.6
13
NCI Comprehensive
Active Research Program
52.6
14
NCI Comprehensive
Active Research Program
52.6
1552.6
16
NCI Comprehensive
Active Research Program
52.6
17
NCI Comprehensive
Active Research Program
52.6
18
NCI Comprehensive
Active Research Program
52.6
19
NCI Comprehensive
Active Research Program
52.6
20
NCI Comprehensive
Active Research Program
52.6
21
NCI Comprehensive
Active Research Program
52.6
22
NCI Comprehensive
Active Research Program
52.6
23
NCI Clinical
Active Research Program
52.6
24
NCI Comprehensive
Active Research Program
52.6
25
Active Research Program
52.6
26
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
52.6
27
NCI Comprehensive
Active Research Program
52.6
28
Active Research Program
52.6
29
Active Research Program
52.6
30
NCI Comprehensive
Active Research Program
52.6
31
NCI Comprehensive
Active Research Program
52.6
32
NCI Comprehensive
Active Research Program
52.6
33
NCI Clinical
Active Research Program
52.6
34
NCI Comprehensive
Active Research Program
52.6
35
NCI Comprehensive
Active Research Program
52.6
36
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.6
37
Active Research Program
52.6
38
NCI Clinical
Active Research Program
52.6
39
NCI Comprehensive
Active Research Program
52.6
40
Active Research Program
52.6
41
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
52.6
42
Active Research Program
52.6
43
NCI Comprehensive
Active Research Program
52.6
44
Active Research Program
52.6
45
Active Research Program
52.6
46
Active Research Program
52.6
47
NCI Basic_laboratory
Active Research Program
52.6
48
Active Research Program
52.6
49
Active Research Program
52.6
50
Active Research Program
52.6
51
Active Research Program
52.6
52
Active Research Program
52.6
53
Active Research Program
52.6
54
Active Research Program
52.6
55
Active Research Program
52.6
56
Active Research Program
52.6
57
Active Research Program
52.6
5830.1
59
NCI Comprehensive
30.1
6030.1
61
NCI Comprehensive
30.1
62
NCI Comprehensive
30.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →